Investigation launched into certain nitisinone capsules from Sweden
OTTAWA, Sept. 21, 2018 /CNW/ - The Canada Border Services Agency (CBSA) announced today that it is launching an investigation into whether or not certain nitisinone capsules originating in or exported from Sweden are being sold at unfair prices in Canada.
The investigation is the result of a complaint filed by Laboratoires KABS Inc. and its affiliate MendeliKABS Inc. which are both located in Saint-Hubert, Quebec. The complainant (comprised of both companies) alleges that the Canadian industry is facing declines in production, lost sales, reduced profitability, negative returns on investments, underutilization of production capacity and negative effects on growth. The initiation of this investigation does not prevent these goods from being imported into Canada and being made available to users.
Currently, there are 101 special import measures in force, covering a wide variety of products, from steel to refined sugar. These measures have directly helped to protect the Canadian economy and jobs in Canada.
Quick Facts
The subject goods are nitisinone capsules supplied in certain dosages. Nitisinone capsules are orally administered drugs used in the treatment of hereditary tyrosinemia type 1 (HT?1). For more product information, please refer to the CBSA's website.
This is the beginning of an investigation process in which the CBSA and the Canadian International Trade Tribunal (CITT) both play a role. The CITT will begin a preliminary inquiry to determine whether the evidence discloses a reasonable indication that imports are harming Canadian producers and will issue a decision by November 20, 2018.
Concurrently, the CBSA will investigate whether the imports are being sold in Canada at unfair prices, and will make a preliminary decision by December 20, 2018. Should the CBSA's preliminary findings indicate that exports from Sweden are being sold at unfair prices, the investigation will be continued for the purposes of making a final decision by March 20, 2019.
A copy of the Statement of Reasons, which provides more details about the investigation, will be available on the CBSA's website at www.cbsa.gc.ca/sima-lmsi within 15 days.
PT. Bank Rakyat Indonesia (Persero) Tbk (IDX: BBRI) reports a profit of IDR 15.98 trillion for the first quarter of 2024, prompting most analysts to maintain a 'Buy' recommendation on BBRI shares....
In anticipation of Mother's Day, the 135th China Import and Export Fair ("Canton Fair" or "the Fair") partners with leading home textiles enterprises to present a curated selection of gifts and blessings for women worldwide. These high-quality,...
Coway Co., Ltd., the "Best Life Solution Company," today reported its financial results for the first quarter of 2024.
"Coway continues to maintain consistent performance with a revenue that's surpassed 1 trillion won for four consecutive quarters,"...
COCA, the world's first MPC wallet with a non-custodial debit card, is excited to announce that Pavel Matveev, the Founder of Wirex, a leading Web3 money app, has joined its team as a Strategy and Product Advisor.
Under the visionary leadership of...
CACI Limited, a leading data and technology solutions company, has acquired Rowe IT Holdings Limited ("Rowe IT").
Rowe IT provides software engineering, systems integration, data analytics and cloud technologies to a strong roster of government and...
ViewSonic Corp., a leading global provider of visual solutions, today announced that its ambitious targets for achieving net-zero greenhouse gas (GHG) emissions by 2050 have been validated by the Science Based Targets initiative (SBTi). This...